Does anyone know where we stand currently with our peptides as far as use in human trials. If i understand correctly we have been comparing our product to the apparent gold standard "TAT" peptides? I assume TAT peptides are currently already in use in approved medications. I wonder do we need to go through clinical trials with our cpp alone or will it be tested as a complete package with cpp and conjugated drug attached when the time comes?
Large deal struck for Aussie cancer inhibitor drug program, page-42
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.24 |
Change
-0.035(2.75%) |
Mkt cap ! $723.2M | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.27 | $1.22 | $162.1K | 130.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3818 | $1.22 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.24 | 956 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |